Evidence map›Paper›PMID 25853300›Full record

ArticleEuropean journal of human genetics : EJHG2015

PIAS4 is associated with macro/microcephaly in the novel interstitial 19p13.3 microdeletion/microduplication syndrome.

Julián Nevado, Jill A Rosenfeld, Rocío Mena, María Palomares-Bralo, Elena Vallespín, María Ángeles Mori, Jair A Tenorio, Karen W Gripp, Elizabeth Denenberg, Miguel Del Campo and 29 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. [Cardiofaciocutaneous syndrome caused by microdeletion of chromosome 19p13.3: a case report and literature review].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Pathogenic variants inCold Spring Harbor molecular case studies · 2020
    Article
  13. Article
  14. Duplications in 19p13.3 are associated with male infertility.Journal of assisted reproduction and genetics · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 18 institutions in 5 countries.

Julián NevadoSection of Functional and Structural Genomics Instituto de Genética Médica y Molecular (INGEMM)-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Jill A RosenfeldSignature Genomic Laboratories, PerkinElmer Inc., Spokane, WA, USA.ORCID http://orcid.org/0000-0001-5664-7987
Rocío MenaSection of Functional and Structural Genomics Instituto de Genética Médica y Molecular (INGEMM)-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
María Palomares-BraloSection of Functional and Structural Genomics Instituto de Genética Médica y Molecular (INGEMM)-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Elena VallespínSection of Functional and Structural Genomics Instituto de Genética Médica y Molecular (INGEMM)-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
María Ángeles MoriSection of Functional and Structural Genomics Instituto de Genética Médica y Molecular (INGEMM)-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Jair A TenorioSection of Functional and Structural Genomics Instituto de Genética Médica y Molecular (INGEMM)-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Karen W GrippAI DuPont Hospital for Children, Wilmington, DE, USA.
Elizabeth DenenbergAI DuPont Hospital for Children, Wilmington, DE, USA.
Miguel Del CampoHospital Vall D'Hebron, Barcelona, Spain.
Alberto PlajaHospital Vall D'Hebron, Barcelona, Spain.
Rubén Martín-ArenasSection of Functional and Structural Genomics Instituto de Genética Médica y Molecular (INGEMM)-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Fernando Santos-SimarroSection of Clinical Genetics, INGEMM-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Lluis ArmengolQ-Genomics Laboratory, Barcelona, Spain.
Gordon GowansUniversity of Louisville, Kentucky, USA.
María OreraCGC-Genetics, Madrid, Spain.
M Carmen Sanchez-HombreCGC-Genetics, Madrid, Spain.
Esther Corbacho-FernándezCGC-Genetics, Madrid, Spain.
Alberto Fernández-JaénHospital Quirón de Madrid, Madrid, Spain.
Chad Haldeman-EnglertWake Forest University, Winston-Salem, NC, USA.
Sulagna SaittaMedical Genetics Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Holly DubbsThe Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Duban B BénédicteHospital Saint Vincent de Paul, Lille, France.
Xia LiAmeripath Northeast, Shelton, CT, USA.
Lani DevaneyHenry Ford Health System, Sterling Heights, Michigan, USA.
Mary Beth DinulosDartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Stephanie ValleeDartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
M Carmen CrespoSection of Functional and Structural Genomics Instituto de Genética Médica y Molecular (INGEMM)-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Blanca FernándezSection Cytogenetics, INGEMM-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Victoria E Fernández-MontañoSection of Functional and Structural Genomics Instituto de Genética Médica y Molecular (INGEMM)-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Inmaculada Rueda-ArenasSection of Functional and Structural Genomics Instituto de Genética Médica y Molecular (INGEMM)-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
María Luisa de TorresCIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.
Jay W EllisonKaiser Permanente, San Francisco, CA, USA.
Salmo RaskinCenter for Health and Biological Sciences, Pontifícia Universidade Católica do Paraná (PUC-PR), Curitiba, Brazil.
Carlos A Venegas-VegaGenetic Unit Hospital General de México, México, México.
Fernando Fernández-RamírezGenetic Unit Hospital General de México, México, México.
Alicia DelicadoCIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.
Sixto García-MiñaúrCIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.
Pablo LapunzinaCIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.
Hospital Universitario La Paz · ESDartmouth–Hitchcock Medical Center · USDuPont (United States) · USVall d'Hebron Hospital Universitari · ESAmerisourceBergen (United States) · USCedars-Sinai Medical Center · USChildren's Hospital of Philadelphia · USHenry Ford Health System · USHôpital Saint-Vincent-de-Paul · FRHospital General de México · MXHospital Universitario Quirónsalud Madrid · ESKaiser Permanente San Francisco Medical Center · USOryzon Genomics (Spain) · ESPerkinElmer (United States) · USPontifícia Universidade Católica do Paraná · BRUniversidad Autónoma de la Ciudad de México · MXUniversity of Louisville · USWake Forest University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Array comparative genomic hybridization (aCGH) is a powerful genetic tool that has enabled the identification of novel imbalances in individuals with intellectual disability (ID), autistic disorders and congenital malformations. Here we report a 'genotype first' approach using aCGH on 13 unrelated patients with 19p13.3 submicroscopic rearrangement (11 deletions and 2 duplications) and review cases in the literature and in public databases. Shared phenotypic features suggest that these patients represent an interstitial microdeletion/microduplication syndrome at 19p13.3. Common features consist of abnormal head circumference in most patients (macrocephaly with the deletions and microcephaly with the duplications), ID with developmental delay (DD), hypotonia, speech delay and common dysmorphic features. The phenotype is associated with at least a ~0.113 Mb critical region harboring three strong candidate genes probably associated with DD, ID, speech delay and other dysmorphic features: MAP2K2, ZBTB7A and PIAS4, an E3 ubiquitin ligase involved in the ubiquitin signaling pathways, which we hypothesize for the first time to be associated with head size in humans.

Indexed as

Chromosome DeletionChromosome DuplicationChildChild, PreschoolChromosomes, Human, Pair 19Developmental DisabilitiesDNA-Binding ProteinsFemaleHumansInfantMaleMAP Kinase Kinase 2MegalencephalyMicrocephalyPoly-ADP-Ribose Binding ProteinsProtein Inhibitors of Activated STATDNA-Binding ProteinsMAP2K2 protein, humanMAP Kinase Kinase 2PIAS4 protein, humanPoly-ADP-Ribose Binding ProteinsProtein Inhibitors of Activated STATTranscription FactorsZBTB7A protein, human

Identifiers

PMID25853300
PMCPMC4795197
OpenAlexW2076718716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.